Abraham Avigdor
- Especialidad: Hematólogo
- 35 años de experiencia
- Idiomas:Inglés, Hebreo
- Consultas online: disponible
- Consultorio: Israel, Ramat Gan, Centro Médico Sheba
- Director del Instituto de Hematología; fundador y presidente del Grupo de Trabajo Israelí de Linfoma; autor de más de 130 publicaciones científicas.
El Dr. Abraham Avigdor, MD, es director del Instituto de Hematología y codirector de la División de Hematología y Trasplante de Médula Ósea del Centro Médico Sheba. Es un líder internacional en linfomas, CAR‑T y hemato‑oncología avanzada, con más de 35 años de experiencia. Su enfoque clínico incluye linfomas, mieloma múltiple y cánceres hematológicos complejos.
Es pionero en la integración de CAR‑T. Dirige programas de terapia celular y trasplante de médula ósea (autólogo y alogénico). Además, impulsa terapias con células madre y diagnósticos de precisión, incluidos pronósticos basados en PET/TC. Su labor abarca inmunoterapia y regímenes dirigidos, así como el desarrollo de protocolos innovadores basados en datos.
Colabora con LYSA, EMCL y grupos internacionales de PET. Es autor de más de 130 publicaciones. Cargos clave: fundador y presidente del Israeli Lymphoma Working Group, ex presidente del Israeli Lymphoma Study Group y profesor sénior en la Universidad de Tel Aviv. Formación: MD, Universidad Ben‑Gurión; residencia, Centro Médico Sheba; beca posdoctoral, Instituto Weizmann. Premios: Premio de la Knéset, Premio del Ministerio de Salud de Israel y Premio Sackler.
Consulta médica online con Abraham Avigdor
Servicios médicos
- Quimioterapia
- Trasplante de médula ósea
- Terapia CAR-T
- Quimioterapia contra la leucemia
- Plasmaféresis
- Quimioterapia del linfoma
- Trasplante de células madre haploidénticas
- Trasplante alogénico de médula ósea de un donante emparentado
- Trasplante alogénico de médula ósea de un donante no emparentado
- Aféresis terapéutica
- Plasmaféresis DFPP
- Intercambio de plasma
- Aféresis selectiva
- Ultrasonido
- TC (tomografía computarizada)
- Biopsia
- Prueba de sangre de marcador tumoral
- Inmunohistoquímica
- Biopsia de médula ósea
- Consulta Online con Oncólogo
- Resonancia magnética de un área
¿Qué tal su experiencia?
Formación académica
Dr. Abraham Avigdor, MD
Director, Institute of Hematology & Co-Director, Hematology and Bone Marrow Transplantation Division – Sheba Medical Center
Global Leader in Lymphoma, CAR-T Therapy & Advanced Hemato-Oncology
Dr. Abraham Avigdor is a highly distinguished hemato-oncologist with over 35 years of experience, specializing in the treatment of lymphomas, multiple myeloma, and complex blood cancers.
As Director of the Institute of Hematology at Sheba Medical Center, he leads one of the region’s most advanced programs in bone marrow transplantation and cellular therapies, including CAR-T treatment.
Areas of Expertise
- Lymphoma (Primary Focus)
Expert in all types of lymphoma, including Hodgkin and Non-Hodgkin lymphoma- Advanced Hemato-Oncology Treatments
-
- CAR-T Cell Therapy – pioneer in integrating CAR-T into lymphoma and myeloma treatment
- Bone Marrow Transplantation – both autologous and allogeneic transplants
- Stem Cell Therapies and advanced cellular treatments
- Multiple Myeloma
Personalized and innovative treatment strategies for complex cases - Precision Diagnostics
Use of PET/CT imaging as a prognostic tool and integration of biological and immunological therapies
Clinical Leadership & Innovation
Dr. Avigdor is internationally recognized for advancing modern lymphoma care, focusing on:
- Integration of immunotherapy and targeted treatments
- Development of innovative treatment protocols
- Personalized, data-driven patient management
His work has helped shape the use of CAR-T therapy as a standard option in advanced hematologic cancers.
International Research & Collaboration
Dr. Avigdor collaborates with leading global research groups, including:
- LYSA (France) – Lymphoma Study Association
- European Mantle Cell Lymphoma Network (EMCL)
- International PET Study Groups in Lymphoma & Myeloma
He has authored 130+ scientific publications, contributing significantly to advancements in lymphoma treatment and cellular therapies.
Leadership & Academic Roles
- Director, Institute of Hematology, Sheba Medical Center
- Co-Director, Hematology & Bone Marrow Transplant Division
- Founder & President, Israeli Lymphoma Working Group
- Former Chairman, Israeli Lymphoma Study Group (2011–2018)
- Senior Lecturer, Tel Aviv University
- Member, National Hematology Consultation Committee (Health Basket)
Education & Training
- MD, Ben-Gurion University of the Negev
- Residency in Internal Medicine & Hematology, Sheba Medical Center
- Postdoctoral Fellowship in Stem Cell Biology, Weizmann Institute of Science
Awards & Recognition
- Knesset Prize for excellence in medical studies
- Israeli Ministry of Health Award for outstanding physician performance
- Sackler Prize for Research Excellence, Tel Aviv University
Patient-Centered Approach
Dr. Avigdor combines decades of experience, global leadership, and cutting-edge therapies to provide highly personalized care for patients with complex blood cancers.
His approach focuses on:
- Access to the most advanced treatments worldwide
- Multidisciplinary care and precise diagnosis
- Improving survival while maintaining quality of life
A Leading Name in Modern Hemato-Oncology
Through his leadership in CAR-T therapy, bone marrow transplantation, and lymphoma research, Dr. Avigdor offers patients access to one of the most advanced and comprehensive blood cancer programs globally.
También le puede interesar
Pagos y Beneficios
Nuestros servicios no tienen costo
El pago se realiza directamente en la clínica o mediante transferencia a su cuenta bancaria oficial.
Algunas clínicas pueden requerir un depósito como parte de su política.
Pague cómodamente en cuotas flexibles.
Reciba recompensas por recomendar Bookimed a sus amigos.